Staphylococcus lugdunensis peptidoglycan (PGN) (PGN)

Staphylococcus lugdunensis peptidoglycan is a fundamental structural polymer that constitutes the primary component of the bacterial cell wall in this specific coagulase-negative staphylococcus. It is composed of alternating residues of N-acetylglucosamine and N-acetylmuramic acid, which are cross-linked by pentaglycine interpeptide bridges characteristic of the Staphylococcaceae family [1]. This mesh-like scaffold is essential for maintaining the cell's shape and protecting it against high internal osmotic pressure, making it a vital target for antimicrobial therapy [2]. In the context of S. lugdunensis, which is known for its unusual virulence and ability to cause destructive endocarditis, the peptidoglycan layer also serves as a potent pathogen-associated molecular pattern (PAMP) [3]. It is recognized by host pattern recognition receptors such as NOD2, triggering inflammatory responses [4]. Drugs targeting peptidoglycan synthesis, such as vancomycin or oxacillin, disrupt the cross-linking process, leading to bacterial lysis and death [5]. While S. lugdunensis remains susceptible to many cell-wall-active agents, the emergence of resistance mechanisms, such as the acquisition of the mecA gene, poses a significant challenge to effectively targeting this structure [3].

Other names

MureinBacterial cell wallS. lugdunensis PGN

Inhibition of peptidoglycan biosynthesis by binding to D-alanyl-D-alanine precursors (glycopeptides) or inhibiting transpeptidase enzymes (beta-lactams).